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THE VALUE TO THE SURGEON OF PARATHYROID HORMONE 
ASSAYS IN PRIMARY HYPERPARATHYROIDISM 
IAN R. GOUGH,’* NORMAN w. THOMPSON’t AND FREDERICK E. ECKHAUSER’? 
Departments of Surgery, *University of Queensland, Brisbane, Australia, and fSection of General 
Surgery, The University of Michigan, Ann Arbor, Michigan, USA 
The role of various parathyroid hormone (PTH) radio-immunoassays in the diagnosis of primary hyperparathy- 
roidism (PHP) is controversial. A series of 204 patients with surgically proven PHP was studied. Serum total 
calcium, serum ionized calcium, amino (N)-terminal PTH and carboxyl(C)-terminal PTH were assessed in 
relation to the volume and weight of adenomatous or hyperplastic parathyroid tissue excised at operation. N- 
terminal PTH was elevated above the normal laboratory range in only 24% of patients and correlated relatively 
poorly with the volume of abnormal parathyroid tissue (r = 0.20, P = 0.05). C-terminal PTH was elevated 
above the normal range in 91% of patients and had a strong correlation with the volume of abnormal 
parathyroid tissue (r = 0.63, P < 0.001). The correlation coefficients between C-terminal PTH and serum 
total calcium and serum ionized calcium were both 0.63 (P < 0.001). In contrast, there was no correlation 
between N-terminal PTH and serum total calcium (r = -0.02), serum ionized calcium (r = -0.04) or C- 
tcrminal PTH ( r  = 0.09). 
A combination of hypercalcaemia and elevated C-terminal PTH can be regarded as strong diagnostic 
evidence of PHP. Furthermore, the level of C-terminal PTH can assist the surgeon by approximately predicting 
the amount of adenomatous or hyperplastic parathyroid tissue that may be expected at surgical exploration. 
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Introduction 
Persistent hypercalcaemia is the characteristic bio- 
chemical abnormality in primary hyperparathyroid- 
ism (PHP). While other causes of hypercalcaemia 
should be considered and excluded by appropriate 
investigation, the availability of parathyroid 
hormone (PTH) assays permits a confident pre- 
operative diagnosis of PHP to be made in most 
patients. 
Nevertheless, since the discovery of a radio- 
immunoassay for PTH in 1963, the role of PTH 
assays in diagnosis has been controversial. ’** The 
failure of many assays to reveal increased levels of 
PTH in some patients has led to reluctant accept- 
ance of the combination of hypercalcaemia and 
‘inappropriately normal’ PTH as a diagnostic fea- 
ture o f  PHP. This unsatisfactory criterion and much 
of the confusion is accounted for by the multiplicity 
of available assays and variable laboratory 
techniques. 3.4 
PTH is secreted as a single chain polypeptide of 
84 amino acids. The biological activity is believed 
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to be contained in the 1-34 amino acids at the 
amino(N)-terminal end, this fragment having a bio- 
logical half-life of a few minutes. The remainder of 
the molecule containing amino acids 35-84 is re- 
ferred to as the carboxyl(C)-terminal portion and 
has a half-life of approximately 1 h.’ 
The study reported here assessed the diagnostic 
value of standardized assays of C-terminal PTH 
(C-FTH) and N-terminal PTH (N-PTH) in a series 
of 204 patients with surgically and histologically 
proven PHP. 
Methods 
The 204 patients in this series were operated on by 
one surgeon (NWT) using a standardized technique6 
over a 5-year period to April 1984. All patients had 
surgically and histologically proven PHP and had 
been evaluated pre-operatively with either or both 
C-PTH and N-PTH radio-immunoassays according 
to the methods of Hawker et al. (Smith Kline Clini- 
cal Laboratories, Creve Coeur, Missouri).’ The 
PTH assay results were interpreted with reference 
to a normal range for C-PTH of 60-450 pg/ml and 
for N-PTH of 163-347 pg/ml. Serum total calcium 
was interpreted with reference to a normal range of 
8.5-10.5mg/dl and serum ionized calcium was 
interpreted with reference to a normal range of 3.8- 
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4.8 mg/dl. Patients who had elevated serum creati- 
nine or PTH assayed by other methods were not 
included in this series. 
The three diameters (dl ,  d2 and d3) of the para- 
thyroid adenomas were measured and the volume 
of the gland (which approximates a spheroid in 
shape) calculated according to the formula n/6 X 
d ,  X d2 X d3 and expressed in mm'. The volume of 
hypcrplastic parathyroid tissue, when more than 
one gland was enlarged in an individual patient, 
was calculated for each gland and then the volumes 
were added. For each of the 204 patients, data were 
available for parathyroid volume and serum total 
calcium, and either or both C-PTH and N-PTH, on 
specimens taken at the same time. Serum ionized 
calcium data were available for 104 patients. 
A N A L Y S I S  
Initial analysis determined that logarithmic trans- 
formation of all the data for serum total calcium, 
serum ionized calcium, C-PTH, N-FTH and para- 
thyroid volume provided a better approximation of 
a Gaussian (normal) distribution than did the raw 
data, and the following calculations were therefore 
performed with logarithmically transformed data. 
Correlation coefficients testing the degree of asso- 
ciation between each of these variables were per- 
formed by regression analysis using the method of 
least squares. Analyses of variance were performed 
to assess the extent to which each variable inde- 
pendently predicted parathyroid volume. 
Results 
Data from 204 patients were analysed. All of these 
patients had surgically and histologically proven 
PHP; 196 patients had a single adenoma, three had 
two adenomas, and five had multiple gland hyper- 
plasia. The volume of adenomatous or hyperplastic 
parathyroid tissue excised ranged from 28 mm3 to 
18849 mm3 and postoperatively all patients were 
normocalcaemic. 
There were 150 females (age range 12-87 years, 
mean = 56.4 years, s.d. = 15.3) and 54 males (age 
range 13-86 years, mean = 49.6 years, s.d. = 
15.8), the age difference being significantly differ- 
ent (Student's r test, t = 2.75, P < 0.01). There 
was no difference in serum total calcium levels be- 
tween the sexes: in the 150 females mean total cal- 
cium was l l .3 mg/dl, s.d. = l .02, and in the 54 
males mean total calcium was 11.4 mgldl, 
s.d. = I .OO ( r  = 0.65, 0.6 > P > 0.5). Similarly, 
there was no difference in parathyroid volume be- 
tween the sexes: in 150 females mean volume was 
1451 mm3, s.d. = 2406, and in 54 males mean vol- 
ume was 1820 mm3, s.d. = 3297 ( r  = 0.75, 
0.5 > P > 0.4). 
C-PTH was assayed in 185 patients. It was nor- 
mal in  17 and elevated above the normal range in 
168 (91%). Again, there was no difference in C -  
PTH between the sexes: in the 138 females mean C- 
PTH was 1664pg/ml, s.d. = 2984 and in the 47 
males mean C-PTH was 1357pglm1, s.d. = 1036 
( r  = 1.04, 0.3 > P > 0.2). N-PTH was assayed in 
95 patients and was normal in 7 I ,  low in one and 
elevated above the normal range in 23 (24%). N -  
PTH was elevated in only two of the patients in 
whom C-PTH was normal. 
The value of C-PTH in patients with marginal 
hypercalcaemia (serum total calcium of 10.7 mgldl 
or less) was examined and was found to be normal 
in 12 and increased in 46 (79%). C-PTH in patients 
with serum total calcium of 10.8 mgldl or more was 
normal in five and increased in 122 (96%). This 
difference was significant ( J  = 13.38. P < 0.001 ). 
All of the patients had elevated serum total cal- 
cium on at least one test, but on the sample of blood 
on which the simultaneous total calcium and PTH 
was measured, 47 had serum total calcium lcvels in 
the normal range (that is, 77% were elevated). 
There were 104 patients who had both total and 
ionized calcium measured simultaneously and of 
these serum ionized calcium was normal in 25 and 
elevated in 79 (76%). Thirteen patients had normal 
levels of both total and ionized calcium, 18 had 
normal total calcium and elevated ionized calcium, 
12 had elevated total calcium and normal ionized 
calcium, and 61 had elevated levels of both. 
There was a strong positive correlation between 
the level of C-terminal PTH and the volume of 
abnormal parathyroid tissue ( r  = 0.63, P < 0.001). 
In contrast, the correlation between the level of 
N-terminal PTH and the volume of abnormal para- 
thyroid tissue was relatively weak ( r  = 0.20. 
P = 0.05). There was good correlation between 
C-PTH and serum total calcium ( 1  85 patients) and 
C-PTH and serum ionized calcium (89 patients). 
the values being the same for both ( r  = 0.63, 
P < 0.001). In contrast, there was no correlation 
between N-PTH and serum total calcium ( r  = 
-0.02), N-PTH and serum ionized calcium ( r  = 
-0.04) or N-PTH and C-PTH ( r  = 0.09). Table I 
shows a correlation matrix of logarithmically trans- 
formed data in 51 patients in whom total calcium, 
ionized calcium, C-PTH and N-PTH were all avail- 
able from the same blood specimen. 
Analyses of variance were performed to assess 
the extent to which each of the other three variables 
Table 1. Correlation matrix of logarithmically trans- 
formed data 
Total calcium Ionized calcium N-PTH 
Ionized calcium 0.65 
N-PTH -0.02 -0.04 
C-PTH 0.52 0.62 0.09 
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predicted volume independently of C-FTH. The 
correlation between log volume and log total cal- 
cium, serum ionized calcium and N-PTH, after 
adjusting for C-PTH (fitting a linear model to C- 
PTH) was 0.01, 0.05 and 0.09 respectively. None 
of these was significantly different from zero and 
therefore none could be used to improve the predic- 
tion of volume based on C-terminal PTH. The rela- 
tionship of log C-PTH to log volume is shown 
(Fig. 1). The upper and lower lines indicate the 
95% confidence limits for volume for any known 
value of C-PTH. 
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Fig. 1. Correlation between log C-terminal PTH and log 
volume of adenomatous or hyperplastic parathyroid tissue 
( r  = 0.63, P < 0.001). 95% confidence limits are indi- 
cated by the upper and lower lines. 
The weight of abnormal parathyroid tissue was 
available in 48 patients and the range was 65- 
20000mg (mean = 1841 mg, s.d. = 3557). The 
volume of abnormal parathyroid tissue in these 
patients correlated very strongly with the weight 
( r  = 0.90, P CC 0.001). 
The number of false negative and false positive 
diagnoses which may have occurred during the time 
this series was collected was not accurately known 
and therefore the sensitivity and specificity of the 
diagnostic tests could not be calculated. Three addi- 
tional patients with hypercalcaemia and elevated 
C-PTH during the time this series was collected 
probably had PHP but were not included in the 
analysis because their treatment and its outcome 
were not finalized. 
Discussion 
The results of this study show that the C-PTH assay 
was a valuable aid to diagnosis in patients with 
suspected PHP. In contrast, the N-PTH assay was 
of little diagnostic value and the results of this assay 
may even confuse the diagnosis. 
The results of previously published clinical 
studies of PTH assays a? summarized in Tables 2 
and 3. In these studies, C-PTH assays were elevat- 
ed above the normal range in 87% of patients, and 
N-PTH assays were elevated in 67%. Four of the 
studies involved comparisons of C- and N-PTH as- 
says and in each of these the C-PTH assay appeared 
to be superior. 9* 'O,' 3* ' 
There are several methods of assay for C- and 
N-PTH, and there are, in addition, other assays 
towards different aspects of the PTH molecule. Some 
of these assays have not been well-characterized. 
Heterologous PTH assays directed towards both C- 
and N-PTH have been reported to be elevated in 1 I 
of 19," 41 of 56,23 and 18 of 34" patients with 
PHP, but these assays have not been widely used. 
Table 2. C-terminal FTH assays in primary hyperparathyroidism 
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Table 3. N-terminal PTH assays in primary hyperparathyroidism 
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Other assays directed towards the mid-region of the 
PTH molecule have been described and the early 
results appear to be encouraging. wZ4 More recent- 
ly, apparently sensitive and specific double anti- 
body assays for the ‘intact’ PTH molecule have 
been developed. It seems likely that progressive 
improvement in assays will occur and the former 
unsatisfactory status of PTH assays will be resolved 
favourably. 
The present study represents the largest series of 
patients with proven PHP in which the diagnostic 
value of C-PTH and N-PTH assays has been evalu- 
ated. The results indicate that C-PTH was elevated 
in 91% of patients, while N-PTH was elevated in 
only 24%. C-PTH was strongly positively correlat- 
ed with the volume of adenomatous or hyperplastic 
parathyroid tissue, but N-PTH was only weakly 
correlated with parathyroid volume. Furthermore, 
N-PTH was negatively correlated with serum total 
calcium and serum ionized calcium and did not 
correlate with C-PTH. It can therefore be conclud- 
ed that the N-PTH assay used in this study was of 
little diagnostic value, and if it had been the only 
assay used would have been falsely negative in 
about 75% of patients. Although N-PTH assays 
have limited value in the diagnosis of PHP, they 
may still have a potential role in selective venous 
catheterization for the location of parathyroid 
adenomas not found at the first operation, in the 
evaluation of secondary hyperparathyroidism in 
renal failure and in the assessment of parathyroid 
autograft function. 
It would be expected from the demonstrated cor- 
relations that C-PTH levels would tend to be lower 
in patients with lower levels of serum total calcium. 
It is well-recognized that some patients with 
asymptomatic PHP and even some of those with 
symptoms or complications such as renal calculi 
may have mild or intermittent hypercalcaemia. It 
was therefore of interest to examine more closely 
the C-PTH results in patients with serum total 
calcium of 10.7 mg/dl or less on the simultaneous 
blood specimen. Although there was a significantly 
greater proportion of false negative results, the fact 
that 79% of results were abnormally elevated indi- 
cates that the C-PTH assay should be of diagnostic 
value in the majority of even this difficult group of 
patients. It should therefore be rarely necessary in 
the future to base a diagnosis of PHP on the com- 
bination of hypercalcaemia and an inappropriately 
normal PTH assay. 
In this series the ratio of fema1es:males was 
2.8:1, compared with ratios of 2:1 and 2.6:l in 
other large ~ e r i e s . ~ ~ . ’ ~  The females, as would be 
anticipated, were on average 6 years older than the 
males, but there were no other differences regard- 
ing serum total calcium, serum C-PTH or parathy- 
roid volume, indicating that the C-PTH assay is 
likely to be useful in males and females of all ages. 
Single adenomas were found in 96% of patients 
compared with an incidence of 80% in a previous 
series from the University of Michigan Hospitals,” 
and incidences of approximately 76% in other large 
series.2s326 This pattern of pathology would not 
influence the results of the study because the data 
were analysed using the volume of adenomatous or 
hyperplastic parathyroid tissue as the standard. 
Although serum ionized calcium has been report- 
ed to be helpful in the diagnosis of PHP when the 
serum total calcium levels are near the upper limit 
of normal,** it provided no additional information 
in the present study. 
C-PTH was shown to correlate strongly with 
parathyroid volume and therefore it was of interest 
to plot the volume of adenomatous or hyperplastic 
parathyroid tissue relative to levels of C-PTH. A 
similar exercise has been reported previously relat- 
ing the mass of excised phaeochromocytoma tissue 
to levels of urinary vanillyl mandelic acid excre- 
t i ~ n . ’ ~  A recent study of pre-operative serum cal- 
cium and PTH levels concluded that identification 
of the pathological parathyroid glands in PHP could 
not be based on the demonstrated relationship 
between the results of these tests and the size of the 
enlarged glands because the correlations were not 
sufficiently strong.30 These authors reviewed 92 
patients and found correlations between serum cal- 
cium and parathyroid weight ( r  = 0.14, f < 0.001) 
PTH ASSAYS IN PRIMARY HYPERPARATHYROIDISM 385 
and volume (r = 0.144, P < 0.001). They also 
found stronger correlations between immuno-PTH 
levels by three different assays and parathyroid 
weight ( r  = 0.25, 0.4, 0.44, all P < 0.001) and 
volume ( r  = 0.25, 0.26, 0.44. all P < 0.001). 
The most important factor in determining the 
success of parathyroid surgery is the thoroughness 
of the dissection by an experienced surgeon. 
However, the level of a reliable PTH assay, as 
shown in the present study, can be of some assis- 
tance to the surgeon. Volume in mm3 and weight in 
mg are approximately equal and can be regarded as 
equivalent for practical purposes. The surgeon can 
obtain some guidance by reference to data such as 
in Fig. I .  If the minimum volume (or weight) is not 
accounted for by the tissue identified then surgical 
exploration should probably continue. For exam- 
ple, if the patient had a C-PTH level of 2000 p g h l  
there would be a 95% probability that at least 
150 mg of abnormal parathyroid tissue was present 
and a 90% probability that at least 200mg was 
present. 
This study showed that a C-PTH assay was 
elevated in 91 YO of patients with PHP. The C-PTH 
assay correlated well with the amount of aden- 
omatous or hyperplastic parathyroid tissue excised 
at operation. The combination of hypercalcaemia 
and elevation of a sensitive C-PTH assay is 
therefore strong diagnostic evidence of PHP, and 
the levels in an individual patient can give the sur- 
geon some guidance by approximately predicting 
the amount of abnormal parathyroid tissue which 
should be identified at operation. 
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